Phibro Animal Health | PAHC - Операционные расходы





Операционные расходы Изменить Дата
Align Technology USD 862.03M 39.18M 2026-03
ANI Pharmaceuticals USD 217.93M 287.88M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Aurora Cannabis CAD 129.98M 16.05M 2025-12
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Canopy Growth CAD 87.2M 6.22M 2025-12
Corcept Therapeutics USD 214.5M 16.87M 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Henry Schein USD 3.17B 77M 2026-03
Idexx Laboratories USD 778.23M 3.26M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Merck USD 18.17B 8.01B 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Pacira USD 172.75M 20.93M 2026-03
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Supernus Pharmaceuticals USD 1.08B 879.06M 2026-03
Zoetis USD 1.55B 3.85B 2025-12